Dubai, UAE is set to host the 10th UAE Cancer Congress (UAECC) focusing on a broad range of topics in oncology care and management, from October 11 to 13 at the InterContinental Dubai Festival City.

In its 10th edition, UAECC aims to foster best practices in cancer care and management, raise treatment standards at the clinicians’ level for better patient care, discuss latest advances in cancer care, research studies and new treatment methodologies for various cancer diseases.

This year, the UAECC, held under the theme ‘Promoting Excellence in Oncology and Striking away Cancer’, will feature a wide range of sessions on over 14 different oncology sub-specialties focusing on breast cancer, gastrointestinal (GI) cancer, gynaecological oncology, lung care, oncology nursing, palliative care, immuno oncology and head & neck master course.

The event will also host dedicated workshops on breast surgical oncology, cancer imaging, nutrition and a live operative workshop – from Tata Memorial Hospital, India.  

UAECC is expected to attract over 2,500 visitors and more than 40 participating sponsor companies, witness the participation of more than 200 speakers from over 75 countries, feature 17 hands-on workshops including a ‘Live Workshop from Tata Memorial hospital in India’ and showcase over 200 poster presentations designed by students and professionals from the UAE and abroad.

Dr Shaheenah Dawood, President, UAECC, consultant medical oncologist, Mediclinic City Hospital, UAE said, “Our mission at UAE Cancer Congress is to play a crucial part in preparing the community for overcoming issues and challenges in preventing the onset of cancer.”

“As part of our efforts in effectively overcoming this disease in the Middle East and Asia Pacific region, we strive to support the oncology community by partnering, learning and building collaborations with various organizations and coming up with unique initiatives to allow for progress in cancer research. Furthermore, UAECC is the only such congress in the middle east, which has been consistently bringing cutting edge medical research and technology to our doorsteps in the past 10 years,” she added.

Dr Dawood continued: “Cancer treatment is undergoing a revolution where the influx of novel therapies derived from basic research on our immune system has shifted the landscape of modern medicine. In addition, new discoveries in immunotherapy, which seek to use the body’s immune system to help fight cancer, are proving to have a profound impact on cancer treatment and prevention.

“As research and the development of new therapies for different types of cancers is a continuous process requiring great effort, we believe that UAECC is an ideal platform which will serve the needs of the medical and pharmaceutical industry in overcoming this disease.”

UAECC 2018 will be introducing the first Asia Pac Middle East Biosimilar Summit on the sidelines of its main conference, with the aim of building a viable roadmap on the advantages of using biosimilar pharma products as compared to generic drugs.

It will also offer industry experts an opportunity to discuss the pros & cons and misconceptions about biosimilar pharmaceutical products, exchange latest data from the ‘Global Biosimilars Landscape’, explore Case Studies and support pharma and biopharma companies to succeed in the Global Biosimilar Market.

According to the World Health Organization (WHO), cancer is the second leading cause of death accounting for millions of deaths worldwide every year and putting a severe burden on the healthcare infrastructure of many countries around the globe.

While lung, liver, colorectal, stomach and breast cancers are widely prevalent globally, contributing to millions of fatalities, more figures released by the Health Department of Abu Dhabi show that the UAE is witnessing about 4,500 new cases of cancer each year with breast, colorectal and lung cancers mostly impacting patients in the region.

The 10th UAECC is organized by Index Conferences and Exhibitions – a member of Index Holding in partnership with UAE Genetic Disease Association, Oncology Nursing Society, Emirates Urological Society, Tata Memorial Centre and Indian Cooperative Oncology Network, India. – TradeArabia News Service